Hyperuricaemia is associated with increased C-reactive protein concentrations in a large cohort of unselected outpatients

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 8, 2008, Pages

  Lippi, Giuseppe ^a   Targher, Giovanni ^a   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; URIC ACID;

BLOOD; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; HUMAN; HYPERURICEMIA; LETTER; METABOLISM; PREDICTION AND FORECASTING;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; HUMANS; HYPERURICEMIA; PREDICTIVE VALUE OF TESTS; URIC ACID;

EID: 51249120488     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.03.011     Document Type: Letter

References (11)

1. Strazzullo P., and Puig J.G. Uric acid and oxidative stress: relative impact on cardiovascular risk?. Nutr Metab Cardiovasc Dis 17 (2007) 409-414
2. Frohlich M., Imhof A., Berg G., Hutchinson W.L., Pepys M.B., Boeing H., et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23 (2000) 1835-1839
3. Jankowska E.A., Ponikowska B., Majda J., Zymlinski R., Trzaska M., Reczuch K., et al. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure. Int J Cardiol 115 (2007) 151-155
4. Ruggiero C., Cherubini A., Miller III E., Maggio M., Najjar S.S., Lauretani F., et al. Usefulness of uric acid to predict changes in C-reactive protein and interleukin-6 in 3-year period in Italians aged 21 to 98 years. Am J Cardiol 100 (2007) 115-121
5. Ruggiero C., Cherubini A., Ble A., Bos A.J., Maggio M., Dixit V.D., et al. Uric acid and inflammatory markers. Eur Heart J 27 (2006) 1174-1181
6. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
7. Nakagawa T., Hu H., Zharikov S., Tuttle K.R., Short R.A., Glushakova O., et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol 290 (2006) F625-F631
8. Puig J.G., and Ruilope L.M. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 17 (1999) 869-872
9. Strasak A., Ruttmann E., Brant L., Kelleher C., Klenk J., Concin H., et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem (2007 Nov 26) [Epub ahead of print]
10. Kang D.H., Park S.K., Lee I.K., and Johnson R.J. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 16 (2005) 3553-3562
11. Kanellis J., Watanabe S., Li J.H., Kang D.H., Li P., Nakagawa T., et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 416 (2003) 1287-1293